DUSP28 Activators

DUSP28 activators are chemical compounds that enhance the function of DUSP28, a dual-specificity phosphatase, through direct or indirect interaction with the protein and the pathways it is involved in. Sodium orthovanadate, okadaic acid, calyculin A, norcantharidin, cantharidin, sodium fluoride, phosphoramidon, phenylarsine oxide, staurosporine, sanguinarine, forskolin, and epigallocatechin gallate indirectly enhance DUSP28 function by inhibiting phosphatases or kinases that share substrates with DUSP28 or by enhancing the levels of substrates of DUSP28. These inhibitors of phosphatases or kinases increase the phosphorylation status of the substrates of DUSP28, leading to their enhanced activation. Such a process can indirectly enhance the function of DUSP28 by increasing the phosphorylation status of its substrates, leading to their enhanced activation.

Among the list, sodium orthovanadate, okadaic acid, calyculin A, norcantharidin, cantharidin, sodium fluoride, and phenylarsine oxide inhibit protein phosphatases, including types 1 and 2A, serine/threonine phosphatases, and tyrosine phosphatases. These inhibitors lead to an increase in the phosphorylation status of the substrates of DUSP28, thereby indirectly enhancing its function. Phosphoramidon, on the other hand, inhibits neutral endopeptidase, leading to an increase in the levels of peptides that might be DUSP28 substrates. Staurosporine, a potent inhibitor of protein kinases, can indirectly enhance the function of DUSP28 by inhibiting kinases that compete with DUSP28 for the same substrates. Finally, forskolin, an activator of adenylate cyclase, indirectly enhances DUSP28 function by activating cAMP-dependent protein kinases that phosphorylate substrates of DUSP28.